https://observatorio.fm.usp.br/handle/OPI/29331
DC Field | Value | Language |
---|---|---|
dc.contributor | Sistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP | - |
dc.contributor.author | FERREIRA, Cristiane R. | - |
dc.contributor.author | ZHAO, Shuchun | - |
dc.contributor.author | SAHOO, Malaya K. | - |
dc.contributor.author | PINSKY, Benjamin | - |
dc.contributor.author | WEBER, Jenna | - |
dc.contributor.author | LAGE, Luis A. P. C. | - |
dc.contributor.author | PEREIRA, Juliana | - |
dc.contributor.author | ZERBINI, Maria C. N. | - |
dc.contributor.author | NATKUNAM, Yasodha | - |
dc.date.accessioned | 2018-11-21T17:00:02Z | - |
dc.date.available | 2018-11-21T17:00:02Z | - |
dc.date.issued | 2018 | - |
dc.identifier.citation | HUMAN PATHOLOGY, v.80, p.138-144, 2018 | - |
dc.identifier.issn | 0046-8177 | - |
dc.identifier.uri | https://observatorio.fm.usp.br/handle/OPI/29331 | - |
dc.description.abstract | Forkhead box P3 (FOXP3) is a specific marker for regulatory T-cells (Tregs). We report 6 cases of T-cell lymphomas with Treg phenotype based on diffuse positivity for FOXP3 in tumor cells. The patients showed a median age of 56 years with a male predominance. Sites of disease included lymph nodes (4), skin (2), subcutaneous tissue (1) and bone marrow (1). All cases showed monomorphic large cells, some with Hodgkin-like or anaplastic cells. All cases expressed pan T-cell markers and lacked cytotoxic markers; one case showed diffuse PD1 staining. Only one case harbored human T-lymphotrophic virus (HTLV)-1 DNA within tumor cells and was classified as adult T-cell leukemia/lymphoma (ATLL). Among 5 HTLV1-negative cases, 3 were classified as peripheral T-cell lymphoma, not otherwise specified (PTCL, NOS) and 2 fulfilled criteria for ALK-negative anaplastic large cell lymphoma (ALCL) with diffuse and strong CD30 positivity. We concluded that Treg phenotype may be rarely seen in HTLV1-negative cases, such as PTCL, NOS and ALK-negative ALCL. Our findings expand the spectrum of T-cell lymphomas with regulatory phenotype and suggest that consideration should be given to HTLV1 DNA testing in the appropriate clinical setting to rule out ATLL. | - |
dc.description.sponsorship | Sao Paulo Research Foundation (FAPESP) [2016/09180-0] | - |
dc.language.iso | eng | - |
dc.publisher | W B SAUNDERS CO-ELSEVIER INC | - |
dc.relation.ispartof | Human Pathology | - |
dc.rights | restrictedAccess | - |
dc.subject | ATLL | - |
dc.subject | FOXP3 | - |
dc.subject | PTCL-NOS | - |
dc.subject | ALK-ALCL | - |
dc.subject | Regulatory T-Cell | - |
dc.subject | Lymphoma | - |
dc.subject | Immunohistochemistry | - |
dc.subject.other | leukemia-virus | - |
dc.subject.other | lymphotropic virus | - |
dc.subject.other | pd-l1 expression | - |
dc.subject.other | foxp3 expression | - |
dc.subject.other | leukemia/lymphoma | - |
dc.subject.other | leukaemia/lymphoma | - |
dc.subject.other | infiltration | - |
dc.subject.other | prognosis | - |
dc.subject.other | features | - |
dc.subject.other | immunity | - |
dc.title | FOXP3-positive T-cell lymphomas in non-HTLV1 carriers include ALK-negative anaplastic large cell lymphoma: expanding the spectrum of T-cell lymphomas with regulatory phenotype | - |
dc.type | article | - |
dc.rights.holder | Copyright W B SAUNDERS CO-ELSEVIER INC | - |
dc.identifier.doi | 10.1016/j.humpath.2018.06.001 | - |
dc.identifier.pmid | 29898383 | |
dc.subject.wos | Pathology | - |
dc.type.category | original article | - |
dc.type.version | publishedVersion | - |
hcfmusp.author.external | ZHAO, Shuchun:Stanford Univ, Dept Pathol, Sch Med, L235,300 Pasteur Dr, Stanford, CA 94305 USA | - |
hcfmusp.author.external | SAHOO, Malaya K.:Stanford Univ, Dept Pathol, Sch Med, L235,300 Pasteur Dr, Stanford, CA 94305 USA | - |
hcfmusp.author.external | PINSKY, Benjamin:Stanford Univ, Dept Pathol, Sch Med, L235,300 Pasteur Dr, Stanford, CA 94305 USA | - |
hcfmusp.author.external | WEBER, Jenna:Stanford Univ, Dept Pathol, Sch Med, L235,300 Pasteur Dr, Stanford, CA 94305 USA | - |
hcfmusp.author.external | NATKUNAM, Yasodha:Stanford Univ, Dept Pathol, Sch Med, L235,300 Pasteur Dr, Stanford, CA 94305 USA | - |
hcfmusp.description.beginpage | 138 | - |
hcfmusp.description.endpage | 144 | - |
hcfmusp.description.volume | 80 | - |
hcfmusp.origem | WOS | - |
hcfmusp.origem.id | WOS:000447817100017 | - |
hcfmusp.origem.id | 2-s2.0-85052644104 | - |
hcfmusp.publisher.city | PHILADELPHIA | - |
hcfmusp.publisher.country | USA | - |
hcfmusp.relation.reference | Attygalle AD, 2014, HISTOPATHOLOGY, V64, P171, DOI 10.1111/his.12251 | - |
hcfmusp.relation.reference | Bangham CRM, 2011, ADV CANCER RES, V111, P163, DOI 10.1016/B978-0-12-385524-4.00004-0 | - |
hcfmusp.relation.reference | Beltran BE, 2012, APPL IMMUNOHISTO M M, V20, P196, DOI 10.1097/PAI.0b013e318225189f | - |
hcfmusp.relation.reference | Bonzheim I, 2008, AM J CLIN PATHOL, V130, P613, DOI 10.1309/L65GWEQ803PP6VX1 | - |
hcfmusp.relation.reference | Brunetto GS, 2014, J NEUROVIROL, V20, P341, DOI 10.1007/s13365-014-0249-3 | - |
hcfmusp.relation.reference | Chtanova T, 2005, J IMMUNOL, V175, P7837, DOI 10.4049/jimmunol.175.12.7837 | - |
hcfmusp.relation.reference | De Oliveira MSP, 1999, INT J CANCER, V83, P291 | - |
hcfmusp.relation.reference | Fontenot JD, 2003, NAT IMMUNOL, V4, P330, DOI 10.1038/ni904 | - |
hcfmusp.relation.reference | Gualco G, 2009, AM J CLIN PATHOL, V132, P28, DOI 10.1309/AJCP6Q7QMUVGMVMF | - |
hcfmusp.relation.reference | Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490 | - |
hcfmusp.relation.reference | Huang CT, 2014, INTERN MED J, V44, P374, DOI 10.1111/imj.12394 | - |
hcfmusp.relation.reference | Jaffe ES, 2017, WHO CLASSIFICATION T, P190 | - |
hcfmusp.relation.reference | Kamihira S, 2005, CLIN LAB HAEMATOL, V27, P235, DOI 10.1111/j.1365-2257.2005.00698.x | - |
hcfmusp.relation.reference | Karube K, 2004, BRIT J HAEMATOL, V126, P81, DOI 10.1111/j.1365-2141.2004.04999.x | - |
hcfmusp.relation.reference | Karube K, 2008, MODERN PATHOL, V21, P617, DOI 10.1038/modpathol.2008.25 | - |
hcfmusp.relation.reference | Kataoka K, 2015, NAT GENET, V47, P1304, DOI 10.1038/ng.3415 | - |
hcfmusp.relation.reference | Kozako T, 2009, LEUKEMIA, V23, P375, DOI 10.1038/leu.2008.272 | - |
hcfmusp.relation.reference | Kubota T, 1996, AM J HEMATOL, V53, P133 | - |
hcfmusp.relation.reference | Li ZH, 2016, J CANCER, V7, P784, DOI 10.7150/jca.14549 | - |
hcfmusp.relation.reference | Mills AM, 2013, AM J SURG PATHOL, V37, P995, DOI 10.1097/PAS.0b013e31827fcc33 | - |
hcfmusp.relation.reference | OHSHIMA K, 1991, CANCER, V67, P1622, DOI 10.1002/1097-0142(19910315)67:6<1622::AID-CNCR2820670625>3.0.CO;2-1 | - |
hcfmusp.relation.reference | Ohshima K, 2017, WHO CLASSIFICATION T, P363 | - |
hcfmusp.relation.reference | Ohshima K, 2007, CANCER SCI, V98, P772, DOI 10.1111/j.1349-7006.2007.00456.x | - |
hcfmusp.relation.reference | Que Y, 2017, J CANCER, V8, P2018, DOI 10.7150/jca.18683 | - |
hcfmusp.relation.reference | Roncador G, 2005, LEUKEMIA, V19, P2247, DOI 10.1038/sj.leu.2403965 | - |
hcfmusp.relation.reference | Roychoudhuri R, 2015, CURR OPIN IMMUNOL, V33, P101, DOI 10.1016/j.coi.2015.02.003 | - |
hcfmusp.relation.reference | Sakaguchi S, 2001, IMMUNOL REV, V182, P18, DOI 10.1034/j.1600-065X.2001.1820102.x | - |
hcfmusp.relation.reference | Satou A, 2016, HISTOPATHOLOGY, V68, P1099, DOI 10.1111/his.12885 | - |
hcfmusp.relation.reference | SEIKI M, 1983, P NATL ACAD SCI-BIOL, V80, P3618, DOI 10.1073/pnas.80.12.3618 | - |
hcfmusp.relation.reference | Tanaka A, 2017, CELL RES, V27, P109, DOI 10.1038/cr.2016.151 | - |
hcfmusp.relation.reference | Tzankov A, 2008, HAEMATOL-HEMATOL J, V93, P193, DOI 10.3324/haematol.11702 | - |
hcfmusp.relation.reference | Vicente C, 2015, NAT GENET, V47, P1226, DOI 10.1038/ng.3428 | - |
hcfmusp.relation.reference | Wilcox RA, 2009, BLOOD, V114, P2149, DOI 10.1182/blood-2009-04-216671 | - |
hcfmusp.relation.reference | Woodland DL, 2003, CURR OPIN IMMUNOL, V15, P336, DOI 10.1016/S0952-7915(03)00037-2 | - |
hcfmusp.relation.reference | Zhu YM, 2016, ONCOTARGET, V7, P71455, DOI 10.18632/oncotarget.12213 | - |
dc.description.index | MEDLINE | - |
dc.identifier.eissn | 1532-8392 | - |
hcfmusp.citation.scopus | 1 | - |
hcfmusp.scopus.lastupdate | 2022-06-17 | - |
Appears in Collections: | Artigos e Materiais de Revistas Científicas - FM/MCM Artigos e Materiais de Revistas Científicas - FM/MPT Artigos e Materiais de Revistas Científicas - HC/ICESP Artigos e Materiais de Revistas Científicas - HU Artigos e Materiais de Revistas Científicas - LIM/14 Artigos e Materiais de Revistas Científicas - LIM/31 Artigos e Materiais de Revistas Científicas - ODS/03 |
File | Description | Size | Format | |
---|---|---|---|---|
art_FERREIRA_FOXP3positive_Tcell_lymphomas_in_nonHTLV1_carriers_include_ALKnegative_2018.PDF Restricted Access | publishedVersion (English) | 2.71 MB | Adobe PDF | View/Open Request a copy |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.